Informations techniques
Exploitant
Laboratoires PROSTRAKAN PHARMA
Présentation
DROLEPTAN 2,5 mg/ 1ml, solution injectable (IV) B/10 - CIP 561 122-8
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
TFwa2gjtZVSrZkr3